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ABSTRACT
It is unarguable that many countries within the developing economies have not been able to reap
many of the benefits from the innovations in Computer and Information Technologies (CIT) as
they pertain to the advances in healthcare delivery systems. The contributing factors to the
problems in these countries are multifaceted, such as, ethnic, cultural, environmental, governance,
and infrastructural. To address these problems, current efforts have focused mostly on the issues
of disease control and management. However, insufficient attention has been given to the
concomitant problems of medication (drug / prescription) management especially as they relate
to information management between patients, physicians, and pharmacists. In most of these
countries, the absence of integrated and reliable system for management and maintenance of a
patient’s medical history exposes a patient to prescription and dispensation errors and/or mistakes
by physicians and pharmacists, respectively. In this paper, taking cognizance of the infrastructural
and other applicable impediments and deficiencies, the design and implementation of a mobilebased system (henceforth referred to as “iRx”) is presented. This system enables patients,
physicians, and pharmacists to reliably interact in managing and maintaining an individual’s drug
history. This management is subject to the patient’s authorization for anyone to access the
applicable information.
Keywords: Developing economies, drugs/prescriptions delivery, healthcare delivery, mobile
technology, under-developed economies, mHealth.
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1 INTRODUCTION AND LITERATURE REVIEW
Many factors are attributable to the deplorable conditions of healthcare delivery in many developing
countries. According to Ameh (2005), many of the contributing factors are ethnic and cultural; and
exacerbated by poverty, ignorance, lack of resources and health facilities, and bad leadership. Many
of the factors, issues, consequences, disparities, and solutions in healthcare delivery in developing
economies are discussed in da Cruz et al. (2017); WHO (2005); Robertson, DeHart, Tolle, and
Heckerman (2015); and Peters et al. (2008). Based on the findings of Tam et al. (2005) on the
frequency of medical errors in medication prescription, the authors (da Cruz et al., 2017) presented
the development of a medication history from the medical records to measure the factors associated
with medication errors and concluded that medication errors are known to compromise patient
safety.
In Mills (2014), the author finds that increasing attention has been paid to the importance of
healthcare systems in recent years. However, in low- and middle-income countries (LMICs),
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substantial external funding has been provided for disease-specific programs without
commensurate attention to the issues of the broader healthcare infrastructures. In Peters et al.
(2011), the authors synthesized a compendium of strategies to improve health services delivery in
LMICs and analyzed the findings. They provided some suggestions for what works and how to
improve implementation. However, the authors argued that not nearly enough attention has been
paid to demonstrating how to improve services for the poor. They concluded that approaches that
use information intelligently are necessary for successful implementation of health services.
According to Epstein and Bing (2011), "A child in a developing country is 33 times as likely to die
before age five as a child in the industrialized world, and up to 60 percent of these deaths could be
prevented through basic health education, products, and services ...". The authors argued that
developing countries lack delivery systems that can give their populations access to health
information, health technologies, and services, and to high-quality and affordable medications.
After analyzing the pros and cons of the healthcare delivery channels in developing economies, the
authors projected that cell phones, computers, and the Internet are likely to revolutionize the
treatment and prevention of disease as they become more accessible to the developing world.
Addressing the critical challenge of healthcare access in LMICs, Bangdiwala, Fonn, Okoye, and
Tollman (2010) looked at the issue of massive global shortage of workforce resources. They
postulated that a strong workforce is essential, therefore, building the human resources for health
should encompass community health workers, mid-level workers and strengthened primary
healthcare systems. In furthering the consequences of lack of access to health technologies in
developing countries, Frost and Reich (2009) argued that although the issue of access to medicines
and other technologies has risen on the global policy agenda, the focus on certain types of access
barriers (especially pricing and patents) has tended to obscure other important obstacles to access
such as distribution, delivery, and adoption problems.
Worldwide shortage of health professionals is more pronounced in rural areas of developing
countries; and rural and remote inhabitants experience lower life expectancy and poorer health
status according to Strasser, Kam, and Regaladol (2016). The authors concluded that greater health
equity can be achieved via their conceptual framework of access to primary health care, sustainable
rural health service models, rural health workforce supply, and policy implications.
Using the increasing cost of healthcare in developed and developing economies, with the
concomitant effects on healthcare delivery, Anyika (2014) explored the relationship between
environmental uncertainty and health care delivery system in Nigeria. The study was based on
reviewing the dynamics of health care delivery in some developed economies and Nigeria with
regards to methods of adaptation.
Other researchers (including American Public Health Association, 2008) have concluded that many
people in low income countries do not practice rudimentary disease prevention measures such as
keeping water covered, washing vegetables, brushing teeth, vaccinating children, taking the garbage
away from the house and screening windows against flies and mosquitoes. Hospitals and clinics
sometimes have good medicines and vaccines but lack consistent and reliable infrastructure such
as refrigerators, clean syringes and nurses--- to keep them safe and adequately deliver them.
Sometimes needles are reused, spreading disease and infection; and vaccines are given though their
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effectiveness has been compromised by lack of proper preservation (refrigeration). In those
communities, much of the health care duties are taken care of by village midwives, who not only
help deliver children but also perform check-ups, give health care advice, dispense birth control
devices, and provide post-natal care.
Broadly speaking, currently available types of mobile health (mHealth - part of the wider “eHealth”
domain) technologies for patients and healthcare providers are grouped into (a) Mobile health apps
providers, (b) Mobile health apps for consumers (c) Patient portals, (d) Mobile-enabled EHRs (e)
Secure text messaging (STM), (f) Patient monitoring devices, and (g) Telemedicine. These
applications help in clinical decision support during patient visits; patient monitoring, tracking and
follow-up, fitness tracking, facilitating provider/staff and patient communication for test results,
prescription refills, medical record review; ubiquitous access to Electronic Health Records (EHRs)
by providers; securing exchange of messages between devices and office workstations; remote
health monitoring and improve treatment compliance by patients; and real-time review of lab
results, seeing patients, prescribing treatment via cloud-based health information technology.
However, for developing countries healthcare providers mainly use mobile healthcare technologies
for education and awareness, remote data collection, remote monitoring, communication and
training for healthcare workers, disease and epidemic outbreak tracking, and diagnostic and
treatment support. In all cases, there is no single platform for the management and utilization of
patient medical records by stakeholders. In developed countries, different network of healthcare
providers provides their own healthcare applications; however, there are reliable means for
enforcing patient privacy which are lacking in most of the developing countries.
Besides the environmental contributory factors to problems in healthcare in developing countries
such as poor water quality, availability, and sanitation; vector-borne diseases; poor ambient and
indoor air quality; toxic substances; and global environmental change, which are mainly
addressable through government efforts and education, healthcare is still largely technologically
limited. The technological solutions in developing countries, as reviewed above, have not explored
the possibilities of deploying full-scale, mobile-based healthcare delivery system. Achieving this
objective requires addressing one of the major components: mobile-based prescription drug
management – which hitherto has received minor attention. In this paper, we explore the viability
of designing, developing, and deploying an integrable mobile-based prescription management
system that encompasses all the major healthcare stakeholders (Patients, Physicians, and
Pharmacists); and reliably enforces patients’ privacy.
2 RELEVANT BACKGROUND
The United Nations International Standard Industrial Classification (ISIC) categorizes the
healthcare industry as generally consisting of:
1. Hospital activities;
2. Medical and dental practice activities;
3. Other human health activities, which involves activities of, or under the supervision of,
nurses, midwives, physiotherapists, scientific or diagnostic laboratories, pathology clinics,
residential health facilities, or other allied health professions (United Nations, 2008).
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In general, healthcare is the maintenance or improvement of health via the prevention, diagnosis,
and treatment of disease, illness, injury, and other physical and mental impairments in human
beings. A healthcare provider is an institution (such as a hospital or clinic) or person (such as a
physician, nurse, allied health professional or community health worker) that provides preventive,
curative, promotional, rehabilitative or palliative care services in a systematic way to individuals,
families or communities.
Healthcare delivery is the most conspicuous and frequent activity in the healthcare system spectrum.
It encompasses primary, secondary and tertiary levels of care where primary care is the day-to-day
healthcare given by a healthcare provider. Secondary care is the necessary treatment for a short
period of time for a brief but serious illness, injury, or other health condition usually rendered in an
Emergency Room (ER). Tertiary care is specialized consultative healthcare, usually for in-patients
and on-referral from a primary or secondary health professional, in a facility that has personnel and
facilities for advanced medical investigation and treatment.
Healthcare delivery involves interactions between patients, medical professionals (physicians), and
pharmacists. Patients present themselves to physicians for medical diagnoses and treatment, which
usually involves prescribing medications for the patients; the medications are dispensed by the
pharmacists. The interactions between the patients, physicians, and pharmacists with respect to
medications require certain level of efficacy and privacy issues. Physicians need access to current
and historical medication information from a patient; and they also need effective and reliable
means of communication with the pharmacists. In most of the developed economies today, the
prevalence of Information Technology (IT) infrastructure makes it possible and easy for physicians
to have automated access to a patient’s medication history; and to transmit required medication to
specified pharmacists, thereby reducing the propensity for errors and mistakes. Unfortunately, in
many developing economies, due to the absence, instability or inadequacies of the necessary IT
infrastructure, there are no automated real-time means of accessing a patient’s medication history
or transmission of required medications, especially, when a patient visits a non-primary care
physician. These situations pose grave consequences when a patient is uncommunicative or forgets
a critical current medication.
3 ABOUT iRx
iRx is a mobile-based system that allows patients, physicians, and pharmacists to interact in
managing and maintaining a patient’s drug prescription history and other associated medical
history information under the authorization and control of the patient. When an iRx patient visits
an iRx physician, the physician can use the patient’s iRx, subject to the patient’s authorization, to
review the patient’s current medications. The physician can also, subject to the patient’s
authorization, update the patient’s medication history on the patient’s iRx device.
When an iRx patient visits a pharmacist, the pharmacist can also use the patient’s iRx, subject to
the patient’s authorization, to review the patient’s current medications; and update the patient’s
medications accordingly.
An iRx patient will be able to manage his/her medication history (and those of associated
dependents) for those medications that he/she obtained without the assistance of either a physician
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or pharmacist. Besides the usual review by a physician or pharmacist, iRx is equipped with internal
knowledge for drug interaction verification.

Figure 1: iRx Architectural Interfaces
3.1 General Description of iRx
The iRx interface architecture (Fig. 1) is primarily made up of the following:
• Registration and Personal Interface (RPI),
• Prescriptions Management Interface (PMI),
• Prescriptions Interaction Interface (PII),
• Patient Verification Interface (PVI).
The Registration and Personal Interface (RPI) is used to register new iRx members and to update
applicable personal information. During the registration, certain Personal Identifiable Data (PID)
are collected. This interface is also required for the physicians’ and pharmacists’ registration.
The Prescriptions Management Interface (PMI) is used for the management of a patient’s
medications. It is used to maintain the history of active and inactive medications. This interface is
accessible to the patients, physicians, and pharmacists.
The Prescriptions Interaction Interface (PII) is used by the patents, physicians, and pharmacists to
quickly check for drug interaction of a given medication with existing active medications.
The Patient Verification Interface (PVI) is used by the physicians and pharmacists to reliably
verify the identity of a patient. The verification module is also used before any updates by a
physician or pharmacist.
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3.2 iRx Patient/Physician/Pharmacist Registration (RPI)
The registration interface (Fig. 2) is used to register either a patient, physician, or pharmacist.
To register as a patient, certain personally identifiable characteristics of the patient are captured.
Some of these include the full name, gender, phone number, date of birth, and digital photo image.
The quality of the photo image must meet certain minimum features, including the facial attributes
that are enough to generate facial recognition parameters.
Only registered physicians will be able to review and update a patient’s iRx prescriptions. The
registration of a physician involves collecting some personal and professional information of the
physician such as full name, gender, phone number, date of birth, area of specialization,
accreditation, current practice, and digital phone image. In addition to positive verification of the
professional information, a physical verification via live video is performed.

Figure 2: Functional Units for iRx Registration
Only registered pharmacists will be allowed to review and update a patient’s iRx prescriptions.
During a pharmacist’s registration, he/she will be required to provide personal and professional
information like that of a physician except for the area of specialization. Just like a physician, a
pharmacist’s professional information will be verified; and live physical verification will also be
conducted.
No one’s registration will be deemed completed and activated until all verification activities have
been concluded successfully. During any registration, iRx attempts to make sure that no duplicate
registration exists. A unique identification number is generated and sent to the registrant. Also, a
QRC (Quick Response Code) is generated for every registered patient.
3.3 Prescriptions Management (PMI)
iRx prescription management, depicted in Fig. 3, involves either viewing or updating of a patient’s
prescription history. The owner or registered physician or pharmacist is allowed access to
prescription management.
The iRx owner is always allowed access to view or manage their prescriptions (and their
dependents) after successful authentication. The system distinguishes between drug information
entered by patient or physician/pharmacist.
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Figure 3: Functional Units for Prescription Management
Before a physician or pharmacist can access a patient’s iRx prescriptions, he/she must be
authorized by the patient; and the physician or pharmacist must verify that the holder of the iRx
app is the owner (see Physician/Pharmacist Authorization below). After successful verification
and authorization, the requester can then view the necessary information.
In the case of a pharmacist, modifications can be made on the patient’s prescription records. When
creating a new prescription in iRx, pertinent pieces of information about the medication are stored;
these include name, frequency, date filled, expiration date, refill requirements, and prescribing
Physician. However, to save the updated or modified data, the patient will be required to review
and accept the update/modifications on the patient’s mobile device.
As part of the management feature, iRx provides the ability for a patient to electronically transmit
selected prescriptions to any participating pharmacy.
3.3.1 Drug Description and Side Effects
Some of the most useful information when dispensing medications are about the uses, side effects,
and drug interactions associated with the medication. For each medication, IRx provides
information for the patient about the its uses; the various side effects; and the interactions with
other medications that the patient is currently using. IRx also provides other necessary actions in
cases of abuse or emergencies; optimal storage, and helpful notes. These pieces of information
will always be accessible to the patient.
3.3.2 Physician/Pharmacist Authorization
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When a physician or pharmacist needs to view or update a patent’s prescription history, he/she
must scan the secure QRC that represents the patient’s mobile identification. When the patient is
not co-located with the requester, the iRx owner ID number can be used instead of the QRC.
Authorization is granted by a patient to a co-located requester by displaying the associated QRC
of the patient.
3.4 Prescription Interaction Verification (PIV)
The Prescription Interaction Interface (PIV), shown in Fig. 4, enables either the patient, physician,
or pharmacist to check whether a given drug has any adverse interaction with any of the current
active drugs that the patient is taking. To perform this verification by a patient, he/she provides the
iRx authentication information, enters or selects the target drug name, and submits the request.
The verification result is displayed for the patient.
For example, to perform this verification by either a physician or pharmacist, he/she scans the
patient’s iRx ID (QRC) from the patient’s device; enters or selects the drug name; and submits the
request.

Figure 4: Functional Units for Drugs Interaction Verification
3.5 Patient Verification Interface (PVI)
One of the critical elements when accessing a patient’s medical information by others is how to
guarantee or enforce privacy and security of the applicable information. iRx provides a verification
interface that prevents anyone access to a patient’s associated medical information without
authorization by the patient. When a physician or pharmacist needs to either view or update a
patient’s medical information, an authorization must be granted by the patient before the request
can be successfully performed. This authorization can be performed either when the patient is colocated with or remote from the requester. For example, when the patient is co-located with the
requester, the authorization is granted by the patient by displaying the associated QRC for the
requester to scan.
4 IMPLEMENTATION STATUS
A proof-of-concept prototype of iRx has been developed and tested on the Android mobile
platform. It comprises a front-end mobile application and a back-end web server and database. All
the key features and functionalities of the system were included in the prototype such as creating
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and updating a physician or patient; creating, updating, and viewing medical records; and
physician and patient authorization controls. To download and install on your Android device, go
to https://nwosu.net/irx/irx.apk. To download the associated user manual, use
https://nwosu.net/irx/manual.pdf.
5 CONCLUSIONS
The premise of this paper is to explore for an effective solution to infrastructural problems that
effect healthcare delivery, especially as they relate to drugs/prescriptions delivery and
management, in communities in under-developed and developing countries. Evidence has shown
that these infrastructural problems will persist in those communities for a long time. As a result,
solutions that circumvent or do not depend on those infrastructures are needed. iRx is one of such
solutions because of its mobile-based platform. In iRx, both providers (physicians and
pharmacists) and patients can ubiquitously access a patient's relevant medical information. This
system protects a patient's privacy because the patient controls who can and when their medical
information is accessible. With the ability to access a patient's medical information, this enables
the provider to make sound medical decisions, thereby, drastically reducing the potential for errors
that might have resulted in adverse or tragic conditions. A by-product of this system is the possible
elimination of one of the prevalent problems in the target communities – the existence of fake or
quack physicians and pharmacists.
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